• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种预测结肠癌预后和免疫治疗效果的铁死亡相关特征的建立与验证

Establishment and validation of a ferroptosis-related signature predicting prognosis and immunotherapy effect in colon cancer.

作者信息

Li Zhufeng, Yuan Fang, Liu Xin, Wei Jianming, Liu Tong, Li Weidong, Li Chuan

机构信息

Department of General Surgery, Tianjin Medical University General Hospital, Tianjin, China.

Department of Anesthesiology, Tianjin Medical University General Hospital, Tianjin, China.

出版信息

Front Oncol. 2023 May 23;13:1201616. doi: 10.3389/fonc.2023.1201616. eCollection 2023.

DOI:10.3389/fonc.2023.1201616
PMID:37287923
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10243598/
Abstract

BACKGROUND

Ferroptosis, a novel form of regulating cell death, is related to various cancers. However, the role of ferroptosis-related genes (FRGs) on the occurrence and development of colon cancer (CC) needs to be further elucidated.

METHOD

CC transcriptomic and clinical data were downloaded from TCGA and GEO databases. The FRGs were obtained from the FerrDb database. The consensus clustering was performed to identify the best clusters. Then, the entire cohort was randomly divided into the training and testing cohorts. Univariate Cox, LASSO regression and multivariate Cox analyses were used to construct a novel risk model in training cohort. The testing and the merged cohorts were performed to validate the model. Moreover, CIBERSORT algorithm analyze TIME between high- and low- risk groups. The immunotherapy effect was evaluated by analyzing the TIDE score and IPS between high- and low- risk groups. Lastly, RT-qPCR were performed to analyze the expression of the three prognostic genes, and the 2-years OS and DFS between the high- and low- risk groups of 43 clinical CC samples to further validate the value of the risk model.

RESULTS

SLC2A3, CDKN2A, and FABP4 were identified to construct a prognostic signature. Kaplan-Meier survival curves showed that OS between the high- and low-risk groups were statistically significant (p<0.001, p<0.001, p<0.001). TIDE score and IPS were higher in the high-risk group (p<0.005, p<0.005, p<0.001, p = 3e-08, p = 4.1e-10). The clinical samples were divided into high- and low- risk groups according to the risk score. There was a statistical difference in DFS (p=0.0108).

CONCLUSION

This study established a novel prognostic signature and provided more insight into the immunotherapy effect of CC.

摘要

背景

铁死亡是一种新型的细胞死亡调控形式,与多种癌症相关。然而,铁死亡相关基因(FRGs)在结肠癌(CC)发生发展中的作用尚需进一步阐明。

方法

从TCGA和GEO数据库下载CC转录组和临床数据。从FerrDb数据库获取FRGs。进行一致性聚类以确定最佳聚类。然后,将整个队列随机分为训练队列和测试队列。在训练队列中使用单因素Cox、LASSO回归和多因素Cox分析构建一个新的风险模型。在测试队列和合并队列中对该模型进行验证。此外,使用CIBERSORT算法分析高风险组和低风险组之间的肿瘤免疫微环境(TIME)。通过分析高风险组和低风险组之间的TIDE评分和免疫预测评分(IPS)评估免疫治疗效果。最后,进行RT-qPCR分析三个预后基因的表达,并分析43例临床CC样本高风险组和低风险组之间的2年总生存期(OS)和无病生存期(DFS),以进一步验证风险模型的价值。

结果

鉴定出溶质载体家族2成员3(SLC2A3)、细胞周期蛋白依赖性激酶抑制剂2A(CDKN2A)和脂肪酸结合蛋白4(FABP4)以构建一个预后特征。Kaplan-Meier生存曲线显示,高风险组和低风险组之间的OS具有统计学意义(p<0.001,p<0.001,p<0.001)。高风险组的TIDE评分和IPS更高(p<0.005,p<0.005,p<0.001,p = 3e-08,p = 4.1e-10)。根据风险评分将临床样本分为高风险组和低风险组。DFS存在统计学差异(p = 0.0108)。

结论

本研究建立了一种新的预后特征,并为CC的免疫治疗效果提供了更多见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd54/10243598/91b942c13273/fonc-13-1201616-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd54/10243598/efbcf894638c/fonc-13-1201616-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd54/10243598/5adf80d7ae68/fonc-13-1201616-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd54/10243598/78760b9f7470/fonc-13-1201616-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd54/10243598/b3c10dba0503/fonc-13-1201616-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd54/10243598/28ce2c5344d6/fonc-13-1201616-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd54/10243598/f41ec49922d8/fonc-13-1201616-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd54/10243598/b1058fa8639a/fonc-13-1201616-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd54/10243598/3e6bcb0cc264/fonc-13-1201616-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd54/10243598/91b942c13273/fonc-13-1201616-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd54/10243598/efbcf894638c/fonc-13-1201616-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd54/10243598/5adf80d7ae68/fonc-13-1201616-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd54/10243598/78760b9f7470/fonc-13-1201616-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd54/10243598/b3c10dba0503/fonc-13-1201616-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd54/10243598/28ce2c5344d6/fonc-13-1201616-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd54/10243598/f41ec49922d8/fonc-13-1201616-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd54/10243598/b1058fa8639a/fonc-13-1201616-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd54/10243598/3e6bcb0cc264/fonc-13-1201616-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd54/10243598/91b942c13273/fonc-13-1201616-g009.jpg

相似文献

1
Establishment and validation of a ferroptosis-related signature predicting prognosis and immunotherapy effect in colon cancer.一种预测结肠癌预后和免疫治疗效果的铁死亡相关特征的建立与验证
Front Oncol. 2023 May 23;13:1201616. doi: 10.3389/fonc.2023.1201616. eCollection 2023.
2
Construction of a ferroptosis-related five-lncRNA signature for predicting prognosis and immune response in thyroid carcinoma.构建用于预测甲状腺癌预后和免疫反应的铁死亡相关五lncRNA特征
Cancer Cell Int. 2022 Sep 29;22(1):296. doi: 10.1186/s12935-022-02674-z.
3
Prediction of overall survival based upon a new ferroptosis-related gene signature in patients with clear cell renal cell carcinoma.基于铁死亡相关基因特征预测透明细胞肾细胞癌患者的总生存期。
World J Surg Oncol. 2022 Apr 14;20(1):120. doi: 10.1186/s12957-022-02555-9.
4
Ferroptosis and cuproptosis prognostic signature for prediction of prognosis, immunotherapy and drug sensitivity in hepatocellular carcinoma: development and validation based on TCGA and ICGC databases.用于预测肝细胞癌预后、免疫治疗及药物敏感性的铁死亡和铜死亡预后特征:基于TCGA和ICGC数据库的构建与验证
Transl Cancer Res. 2023 Jan 30;12(1):46-64. doi: 10.21037/tcr-22-2203. Epub 2022 Dec 19.
5
A Novel Prognostic Model Based on Ferroptosis-Related Gene Signature for Bladder Cancer.一种基于铁死亡相关基因特征的膀胱癌新型预后模型。
Front Oncol. 2021 Aug 6;11:686044. doi: 10.3389/fonc.2021.686044. eCollection 2021.
6
Identification of a Novel Ferroptosis-Related Gene Signature for Predicting Prognosis and Responsiveness to Immunotherapy in Hepatocellular Carcinoma.鉴定一种用于预测肝细胞癌预后和免疫治疗反应的新型铁死亡相关基因特征
J Hepatocell Carcinoma. 2023 Jan 10;10:1-16. doi: 10.2147/JHC.S395563. eCollection 2023.
7
Identification of the ferroptosis-related long non-coding RNAs signature to improve the prognosis prediction and immunotherapy response in patients with NSCLC.鉴定与铁死亡相关的长非编码 RNA 特征,以改善 NSCLC 患者的预后预测和免疫治疗反应。
BMC Med Genomics. 2021 Dec 3;14(1):286. doi: 10.1186/s12920-021-01133-4.
8
A Novel Prognosis Signature Based on Ferroptosis-Related Gene DNA Methylation Data for Lung Squamous Cell Carcinoma.基于铁死亡相关基因DNA甲基化数据的肺鳞状细胞癌新型预后标志物
J Oncol. 2022 Sep 12;2022:9103259. doi: 10.1155/2022/9103259. eCollection 2022.
9
Construction and analysis of a novel ferroptosis-related gene signature predicting prognosis in lung adenocarcinoma.构建和分析一个新的与铁死亡相关的基因签名,预测肺腺癌的预后。
FEBS Open Bio. 2021 Nov;11(11):3005-3018. doi: 10.1002/2211-5463.13288. Epub 2021 Oct 16.
10
Ferroptosis-related lncRNA signature predicts prognosis and immunotherapy efficacy in cutaneous melanoma.铁死亡相关长链非编码RNA特征预测皮肤黑色素瘤的预后和免疫治疗疗效。
Front Surg. 2022 Jul 21;9:860806. doi: 10.3389/fsurg.2022.860806. eCollection 2022.

本文引用的文献

1
N-acetyltransferase 10 promotes colon cancer progression by inhibiting ferroptosis through N4-acetylation and stabilization of ferroptosis suppressor protein 1 (FSP1) mRNA.N-乙酰基转移酶 10 通过 N4-乙酰化和稳定铁死亡抑制蛋白 1(FSP1)mRNA 抑制铁死亡来促进结肠癌的进展。
Cancer Commun (Lond). 2022 Dec;42(12):1347-1366. doi: 10.1002/cac2.12363. Epub 2022 Oct 8.
2
A Systematic Framework for Identifying Prognostic Genes in the Tumor Microenvironment of Colon Cancer.一种用于鉴定结肠癌肿瘤微环境中预后基因的系统框架。
Front Oncol. 2022 May 19;12:899156. doi: 10.3389/fonc.2022.899156. eCollection 2022.
3
Interaction between macrophages and ferroptosis.
巨噬细胞与铁死亡的相互作用。
Cell Death Dis. 2022 Apr 16;13(4):355. doi: 10.1038/s41419-022-04775-z.
4
The Cell Cycle-Associated Protein CDKN2A May Promotes Colorectal Cancer Cell Metastasis by Inducing Epithelial-Mesenchymal Transition.细胞周期相关蛋白CDKN2A可能通过诱导上皮-间质转化促进结肠癌细胞转移。
Front Oncol. 2022 Mar 3;12:834235. doi: 10.3389/fonc.2022.834235. eCollection 2022.
5
An 11-gene signature for the prediction of systemic recurrences in colon adenocarcinoma.用于预测结肠腺癌全身复发的11基因特征。
Gastroenterol Rep (Oxf). 2021 Aug 25;9(5):451-460. doi: 10.1093/gastro/goab023. eCollection 2021 Oct.
6
Spatial architecture of the immune microenvironment orchestrates tumor immunity and therapeutic response.免疫微环境的空间结构协调肿瘤免疫和治疗反应。
J Hematol Oncol. 2021 Jun 25;14(1):98. doi: 10.1186/s13045-021-01103-4.
7
Innate immune cells in the tumor microenvironment.肿瘤微环境中的固有免疫细胞。
Cancer Cell. 2021 Jun 14;39(6):725-729. doi: 10.1016/j.ccell.2021.05.016.
8
Expression and Prognostic Characteristics of Ferroptosis-Related Genes in Colon Cancer.结肠癌中铁死亡相关基因的表达及预后特征
Int J Mol Sci. 2021 May 26;22(11):5652. doi: 10.3390/ijms22115652.
9
A Novel Ferroptosis Related Gene Signature for Prognosis Prediction in Patients With Colon Cancer.一种用于预测结肠癌患者预后的新型铁死亡相关基因特征
Front Oncol. 2021 May 11;11:654076. doi: 10.3389/fonc.2021.654076. eCollection 2021.
10
Development of a Metastasis-Related Immune Prognostic Model of Metastatic Colorectal Cancer and Its Usefulness to Immunotherapy.转移性结直肠癌转移相关免疫预后模型的建立及其在免疫治疗中的应用
Front Cell Dev Biol. 2021 Jan 28;8:577125. doi: 10.3389/fcell.2020.577125. eCollection 2020.